SMTL ID : 8xlm.1

Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state)

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-1-mer

Ligands

8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 2 residues within 4Å: Chain A: N.712, L.917 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 2 residues within 4Å: Chain A: N.796, S.798 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 4 residues within 4Å: Chain B: N.712, L.917, Q.921, Q.1066 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:L.917 NAG-NAG.4: 2 residues within 4Å: Chain B: N.796, S.798 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 4 residues within 4Å: Chain C: N.712, L.917, Q.921, Q.1066 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:L.917 NAG-NAG.6: 3 residues within 4Å: Chain C: N.796, S.798, Q.799 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 3 residues within 4Å: Chain D: N.35, E.39, Q.322 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 3 residues within 4Å: Chain D: K.398, D.525, N.528 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.7: 2 residues within 4Å: Chain D: K.8, N.72 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.10: 10 residues within 4Å: Chain D: N.85, H.327, P.328, A.330, E.357, H.360, E.384, F.486, Y.492, R.496 2 PLIP interactions: 2 interactions with chain D Hydrophobic interactions: D:Y.492 Hydrogen bonds: D:R.496, D:Y.492, D:Y.492

33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.11: 2 residues within 4Å: Chain A: H.334, N.338 Ligand excluded by PLIP NAG.12: 3 residues within 4Å: Chain A: N.118, N.121, V.123 Ligand excluded by PLIP NAG.13: 4 residues within 4Å: Chain A: T.104, T.105, I.228, N.229 Ligand excluded by PLIP NAG.14: 3 residues within 4Å: Chain A: E.276, N.277, T.279 Ligand excluded by PLIP NAG.15: 1 residues within 4Å: Chain A: N.611 Ligand excluded by PLIP NAG.16: 4 residues within 4Å: Chain A: Y.702, N.704 Chain C: I.789, Y.791 Ligand excluded by PLIP NAG.17: 4 residues within 4Å: Chain A: A.701, E.1067, K.1068, N.1069 Ligand excluded by PLIP NAG.18: 2 residues within 4Å: Chain A: N.1093, H.1096 Ligand excluded by PLIP NAG.19: 1 residues within 4Å: Chain A: N.1129 Ligand excluded by PLIP NAG.20: 3 residues within 4Å: Chain A: N.326, P.574, Q.575 Ligand excluded by PLIP NAG.21: 3 residues within 4Å: Chain B: N.118, T.120, V.123 Ligand excluded by PLIP NAG.22: 3 residues within 4Å: Chain B: E.128, N.159, N.160 Ligand excluded by PLIP NAG.23: 4 residues within 4Å: Chain B: T.104, N.229, T.231 Chain C: E.460 Ligand excluded by PLIP NAG.24: 3 residues within 4Å: Chain B: N.275, N.277 Chain C: K.553 Ligand excluded by PLIP NAG.25: 1 residues within 4Å: Chain B: N.611 Ligand excluded by PLIP NAG.26: 1 residues within 4Å: Chain B: N.652 Ligand excluded by PLIP NAG.27: 3 residues within 4Å: Chain A: I.789, Y.791 Chain B: N.704 Ligand excluded by PLIP NAG.28: 2 residues within 4Å: Chain B: A.701, N.1069 Ligand excluded by PLIP NAG.29: 2 residues within 4Å: Chain B: N.1093, H.1096 Ligand excluded by PLIP NAG.30: 1 residues within 4Å: Chain B: N.1129 Ligand excluded by PLIP NAG.31: 3 residues within 4Å: Chain C: Y.24, T.25, N.57 Ligand excluded by PLIP NAG.32: 7 residues within 4Å: Chain C: V.116, N.118, T.120, N.121, V.122, V.123, E.151 Ligand excluded by PLIP NAG.33: 2 residues within 4Å: Chain C: N.229, T.231 Ligand excluded by PLIP NAG.34: 2 residues within 4Å: Chain C: N.275, N.277 Ligand excluded by PLIP NAG.35: 3 residues within 4Å: Chain C: N.611, T.613, E.614 Ligand excluded by PLIP NAG.36: 3 residues within 4Å: Chain C: Y.650, V.651, N.652 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain B: Y.791 Chain C: N.704 Ligand excluded by PLIP NAG.38: 3 residues within 4Å: Chain C: E.1067, K.1068, N.1069 Ligand excluded by PLIP NAG.39: 4 residues within 4Å: Chain C: N.1093, T.1095, H.1096, F.1098 Ligand excluded by PLIP NAG.40: 1 residues within 4Å: Chain C: N.1129 Ligand excluded by PLIP NAG.41: 3 residues within 4Å: Chain C: K.109, N.159, N.160 Ligand excluded by PLIP NAG.42: 2 residues within 4Å: Chain D: P.303, N.304 Ligand excluded by PLIP NAG.43: 4 residues within 4Å: Chain D: D.413, N.414, E.415, W.576 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nomai, T. et al., Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Biorxiv (2024)

Release Date

2024-05-01

Peptides

Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Spike glycoprotein

Processed angiotensin-converting enzyme 2

Related Entries With Identical Sequence